Tilray Medical has received approval for a new medical cannabis extract in Portugal, known as Tilray Oral Solution THC10:CBD10 or Tilray Solução Oral THC10:CBD10. This approval follows the previous approval of Tilray Medical whole flower THC 18 and the first cannabis extract in Portugal earlier this year.
For further details, you may refer to the full story here.
In the realm of cannabis news, Herbal Dispatch has announced record revenue and positive net income, Curaleaf has unveiled plans for New York retail expansion with two new medical dispensaries, and Beboe is making waves in New York’s cannabis scene with premium socially dosed edible and vape products.
Additionally, the top cannabis stocks from July 19 to July 25, 2024, include Tilray Brands Inc., Canopy Growth Corp, Medipharm Labs Corp, Nextleaf Solutions Ltd, Curaleaf Holdings Inc, and Delta 9 Cannabis Inc.
Please note that the information provided in this article is for informational purposes only and should not be considered as investment advice. For full disclaimer information, please refer here.
(Top photo: File)
